JANE STREET GROUP, LLC - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 66 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2020. The put-call ratio across all filers is 1.33 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANE STREET GROUP, LLC ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q2 2024$628,500
+452.2%
203,398
+361.0%
0.00%
Q1 2024$113,827
-52.8%
44,119
-54.3%
0.00%
Q4 2023$241,272
-41.6%
96,509
-29.2%
0.00%
Q1 2023$412,952
+66.3%
136,288
+27.9%
0.00%
Q4 2022$248,253
+589.6%
106,546
+464.7%
0.00%
Q3 2022$36,000
-68.7%
18,869
-55.7%
0.00%
Q2 2022$115,000
-91.1%
42,601
-90.2%
0.00%
Q1 2022$1,296,000
-60.6%
434,714
-48.6%
0.00%
Q4 2021$3,293,000
+66.6%
846,380
+83.7%
0.00%
Q3 2021$1,977,000
+924.4%
460,861
+624.2%
0.00%
Q2 2021$193,000
-63.8%
63,635
-60.3%
0.00%
Q1 2021$533,000
-45.1%
160,362
-41.4%
0.00%
Q4 2020$971,000
+1732.1%
273,464
+1525.3%
0.00%
Q3 2020$53,000
-72.7%
16,825
-84.2%
0.00%
Q2 2020$194,000
+165.8%
106,181
+45.6%
0.00%
Q1 2020$73,000
-79.0%
72,925
-56.4%
0.00%
-100.0%
Q2 2019$348,000
+411.8%
167,188
+1422.2%
0.00%
Q3 2017$68,000
-56.1%
10,983
-56.7%
0.00%
-100.0%
Q3 2015$155,00025,3740.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2020
NameSharesValueWeighting ↓
QVT Financial LP 16,013,540$39,233,0001.19%
ARMISTICE CAPITAL, LLC 1,940,000$4,753,0001.12%
DAFNA Capital Management LLC 234,000$573,0000.50%
Alpha Wave Global, LP 1,655,162$4,055,0000.43%
Telemetry Investments, L.L.C. 150,000$368,0000.21%
LADENBURG THALMANN FINANCIAL SERVICES INC. 5,294,945$12,972,0000.18%
SABBY MANAGEMENT, LLC 792,617$1,942,0000.11%
K2 PRINCIPAL FUND, L.P. 443,887$1,088,0000.10%
Anson Funds Management LP 105,085$257,0000.08%
DIALECTIC CAPITAL MANAGEMENT, LP 25,000$61,0000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders